Outcomes Of Daratumumab-Containing Regimens in The Treatment of Relapsed Multiple Myeloma: Real-World Data from The Canadian Myeloma Research Group Database by LaurenEBS | Jun 13, 2021
Survival And Outcomes of Newly Diagnosed Multiple Myeloma Patients Stratified by Transplant Status Diagnosed Between 2007-2018: Real-World Analysis from the Canadian Myeloma Research Group Database by LaurenEBS | Jun 13, 2021
Carfilzomib-Containing Regimens For Relapsed Multiple Myeloma In A Real-World Setting: A Multi-Institutional Report From The Canadian Myeloma Research Group (CMRG) by LaurenEBS | Jun 13, 2021
Maintenance Therapy but Not Tandem Autologous Stem Cell Transplant (ASCT) Improves outcomes in Multiple Myeloma with High-Risk Cytogenetics: Results from The Canadian Myeloma Research Group (CMRG) Database by LaurenEBS | Dec 13, 2020
Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database by LaurenEBS | Dec 13, 2020
